A Complex Network of Interactions between S282 and G283 of Hepatitis C Virus Nonstructural Protein 5B and the Template Strand Affects Susceptibility to Sofosbuvir and Ribavirin

• Type of Material: Article
• Authors: Anupriya Kulkarni, McGill University; Masad J. Damha, McGill University; Raymond Schinazi, Emory University; Hongmei Mo, Gilead Sciences, Inc.; Brian Doehle, Gilead Sciences, Inc.; Selena M. Sagan, McGill University; Matthias Götte, McGill University
• Language: English
• Date: 2016-04-01
• Publisher: American Society for Microbiology
• Publication Version: Final Published Version
• Copyright Statement: © 2016, American Society for Microbiology. All Rights Reserved.
• Final Published Version (URL): http://dx.doi.org/10.1128/AAC.02436-15
• Title of Journal or Parent Work: Antimicrobial Agents and Chemotherapy
• ISSN: 0066-4804
• Volume: 60
• Issue: 4
• Start Page: 2018
• End Page: 2027
• Keywords: NS5B POLYMERASE; NUCLEOTIDE; Pharmacology & Pharmacy; MECHANISM; Microbiology; Science & Technology; RESISTANCE; Life Sciences & Biomedicine; INHIBITION; DEPENDENT RNA-POLYMERASE; REPLICATION; HCV INFECTION
• Research Categories: Chemistry, Biochemistry; Biology, Microbiology; Health Sciences, Pharmacology

Abstract

The hepatitis C virus (HCV) RNA-dependent RNA-polymerase NS5B is essentially required for viral replication and serves as a prominent drug target. Sofosbuvir is a prodrug of a nucleotide analog that interacts selectively with NS5B and has been approved for HCV treatment in combination with ribavirin. Although the emergence of resistance to sofosbuvir is rarely seen in the clinic, the S282T mutation was shown to decrease susceptibility to this drug. S282T was also shown to confer hypersusceptibility to ribavirin, which is of potential clinical benefit. Here we devised a biochemical approach to elucidate the underlying mechanisms. Recent crystallographic data revealed a hydrogen bond between S282 and the 2'-hydroxyl of the bound nucleotide, while the adjacent G283 forms a hydrogen bond with the 2'-hydroxyl of the residue of the template that base pairs with the nucleotide substrate. We show that DNA-like modifications of the template that disrupt hydrogen bonding with G283 cause enzyme pausing with natural nucleotides. However, the specifically introduced DNA residue of the template reestablishes binding and incorporation of sofosbuvir in the context of S282T. Moreover, the DNA-like modifications of the template prevent the incorporation of ribavirin in the context of the wild-type enzyme, whereas the S282T mutant enables the binding and incorporation of ribavirin under the same conditions. Together, these findings provide strong evidence to show that susceptibility to sofosbuvir and ribavirin depends crucially on a network of interdependent hydrogen bonds that involve the adjacent residues S282 and G283 and their interactions with the incoming nucleotide and complementary template residue, respectively.